A new way to see liver health
Avoids biopsy risk of complications
Detects change more reliably than competitors
Outperforms other tests in the detection and stratification of MASH
Correlates with biopsy features (NAS and fibrosis)
Lower failure rates compared to elastography, even in high BMI
More robust compared to other tests in MASLD, MASH, and CLD patients
No need for contrast agent, needles, or exposure to radiation
Prognostic value of both major liver and cardiovascular outcomes
High cT1 linked to CVD events and mortality
Predicts CVD hospitalisation in a population cohort where PDFF and FIB-4 do not
Supports broader risk stratification
cT1-based care pathways deliver the lowest per-patient cost compared to biopsy or FibroScan (VCTE)
Reduces need for specialist visits, biopsies, and imaging procedures, streamlining the patient pathway
Demonstrated favorable cost-effectiveness (ICER ~€4,900 per QALY) across multiple healthcare systems
Minimizes complication costs and improves safety versus invasive liver biopsy
Supports scalable adoption of noninvasive liver assessment within constrained healthcare budgets
Single scan provides a comprehensive liver assessment
Accurate, repeatable data for confident diagnosis
Enables timely intervention
Enables personalised and preventative treatment
Identifies MASH patients eligible for treatment
Standardized, reproducible & repeatable metrics ensuring consistent results
cT1 is a clinically meaningful metric that enables diagnosis and effective monitoring of treatment response.
LiverMultiScan has widespread insurance coverage.
Delivered through MRI, LiverMultiScan is a safe and painless procedure that does not require specialist equipment or contrast agents.
Results are presented in an intuitive and easy to understand report.
LiverMultiScan is approved for use on Siemens, GE and Philips MRI machines at both 1.5 and 3 Tesla. It makes use of existing manufacturer software requiring only configuration to establish a suitable LiverMultiScan sequence.
LiverMultiScan is a contrast free scan. Due to an acquisition time of approximately 5 minutes it can be combined alongside other protocols if used prior to contrast administration.
LiverMultiScan leverages existing DICOM image exchange platforms to access data with native support for Ambra, Powershare and many others already established. All communication is done through the DICOM protocol simplifying the data transfer and implementation process significantly.
LiverMultiScan is hosted across several US data centers enabling data storage and processing activities to be performed and reside in the originating region. Perspectum actively maintains an ISO 27001 information security certification ensuring that your data is safe and secure. For UK and EU hosting options please contact us directly.
Do you have questions about our clinical or pharmaceutical solutions?
Our team is here to help. Simply share your question and your email address, and a member of the team will get back to you directly.